Pharmacy Solutions sp. z o.o.

Business and other management consultancy activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2011-01-17
Share capital
605,000.00 PLN
Average employment (FTE)
19.6 (2025)
Activity description

Pharmacy Solutions operates the Apteki 4 Pory Roku brand and its Partner Pharmacy Network, which has supported pharmacies across Poland for 15 years. The company supplies pharmacies with products at attractive prices and works with leading drug manufacturers. It is part of the Investcare Pharmaceutical Group and runs health campaigns, including on diabetes and obesity.

Registered address
ul. Białobrzeska 45, 41-409 Mysłowice, Poland
Email
Phone
Social media
Electronic delivery address
AE:PL-81869-43491-BVTFR-25

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 32 days early.

  • 202524/06/2026
  • 202410/07/2025
  • 202303/07/2024
  • 202202/06/2023
  • 202101/07/2022
  • 202008/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

City · Mysłowice58 / 439
Top 13%
Voivodeship · Śląskie3,765 / 33,148
Top 11%
Country · Poland34,574 / 297,069
Top 12%

Results vs industry

Revenue
This companyUSD 4.74mMedianUSD 66.55kAverageUSD 1.21m
Net profit
This companyUSD 121.63kMedianUSD 1.82kAverageUSD 72.96k
Operating costs
This companyUSD 4.56mMedianUSD 50.38kAverageUSD 1.02m
Assets
This companyUSD 2.02mMedianUSD 69.51kAverageUSD 2.58m

Offer

  • Medicinal products for pharmacies
  • Support for partner pharmacies
  • Pharmaceutical care
  • Workshops for pharmacists

Websites

  • apteka4poryroku.plApteki 4 Pory Roku
    WordPress 6.6ElementorGoogle AnalyticsGoogle Tag ManagerLiteSpeed

Trademarks

The company holds 7 active trademarks registered with the Polish Patent Office. 5 marks have expired or were not registered. The first mark was filed in 2010.

MarkNumberClassesStatusProtected until
MEDICARE APTEKA Z.5891123, 5, 8, 9, 10, 25, 28, 29, 30, 32, 33, 35, 38, 39, 41, 42, 44Protected Aug 19, 2035
4 PORY ROKU APTEKA Z.54525035, 44Protected Jul 18, 2032
4 PORY ROKU Z.54524935, 41, 44Protected Jul 18, 2032
APTEKA 4 PORY ROKU Z.54525135, 44Protected Jul 18, 2032
Pharmacy Solutions Z.49148835Protected Oct 10, 2028
MarkProtected until
MEDICARE APTEKA Aug 19, 2035
4 PORY ROKU APTEKA Jul 18, 2032
4 PORY ROKU Jul 18, 2032
APTEKA 4 PORY ROKU Jul 18, 2032
Pharmacy Solutions Oct 10, 2028

Job offers

The company has its own careers page: apteka4poryroku.pl/kariera.

Authorized Representatives

Adam Marcin Pecyna age 50 – Vice President of the Management Board
Agata Stanisława Empfinger age 49 – Attorney-in-fact (joint)
Aneta Stachera-Kula age 42 – Vice President of the Management Board
Anna Palka-Porwit age 49 – Attorney-in-fact (joint)
Katarzyna Czajczyńska age 43 – President of the Management Board

Manner of representation

In the case of a one-person management board, the company is represented by the member of the management board independently, or by two commercial proxies jointly. In the case of a multi-member management board, the company is represented by two members of the management board jointly or by one member of the management board jointly with a commercial proxy, or by two commercial proxies jointly.

Ownership

OwnerSharesShare valueStake
8,336$112,587.7968.8926%
1,882$25,418.6915.5537%
1,882$25,418.6915.5537%

The articles of association require approval of the remaining shareholders for share transfers.

Beneficial owners

Person

Subsidiaries

NameStake
Biocanto Pharma sp. z o.o.
16.6667%
Miropharm sp. z o.o.
99.9901%
Ipharm 5 sp. z o.o.
51%

Capital group

The company belongs to the Investcare (Poland) group, which is its direct owner.

Bank accounts

Registered as a VAT taxpayer on 2011-02-23.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $77,230.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$5,260
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$60,448
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$6,431

Competitors

Name
Hurtownia Farmaceutyczna Bieńkowski sp. j.
UNIT Dose Pharma sp. z o.o.
Przedsiębiorstwo Zaopatrzenia Farmaceutycznego Cefarm-Kielce S.A.
Orion Pharma Poland sp. z o.o.
Interpharma sp. z o.o.
Ewopharma Ag sp. z o.o.
Solpharm sp. z o.o.
Ekspres Apteczny sp. z o.o.
Hurtownia Farmaceutyczna Solinea sp. z o.o.
Biocanto sp. z o.o.

Change history

DateEvent
2024-10-16Address change
2015-09-11PKD change
2014-03-26PKD change
2013-10-10Address change
2011-11-18Share capital increase

FAQ

Last updated: 2026-06-24